Free Trial
NASDAQ:BBH

VanEck Biotech ETF (BBH) Price, Holdings, & News

VanEck Biotech ETF logo
$162.56 +0.52 (+0.32%)
Closing price 08/1/2025 03:58 PM Eastern
Extended Trading
$162.61 +0.05 (+0.03%)
As of 08/1/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About VanEck Biotech ETF (NASDAQ:BBH)

Key Stats

Today's Range
$160.06
$162.66
50-Day Range
$146.33
$165.12
52-Week Range
$135.34
$183.64
Volume
5,112 shs
Average Volume
7,829 shs
Market Capitalization
$343.00 million
Assets Under Management
$342.55 million
Dividend Yield
0.77%
Net Expense Ratio
0.35%
Aggregate Rating
Moderate Buy

ETF Overview

VanEck Biotech ETF Expenses

TypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.35%0.56%0.56%0.54%0.53%
Other Expenses0.00%0.47%0.56%0.52%0.56%
Total Expense0.35%0.75%0.76%0.73%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.50%-0.63%
Net Expense0.35%0.60%0.63%0.63%0.60%
Receive BBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

BBH ETF News Headlines

BBH: Fear Of Price Controls Is Not The Problem
One stock to replace Nvidia
I'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce competitors, dethroning the AI Chip King. But there's a critical component that AI data centers need just as badly as chips. The demand is so massive that a single data center uses enough of it to stretch around the earth eight times. While the media hypes up AI chips, the smart money has found the next big thing. Discover Futurist Eric Fry's "Nvidia-killer" stock ideas.
Are Rate Cuts Bad News For BIZD ETF?
See More Headlines

BBH ETF - Frequently Asked Questions

VanEck Biotech ETF's stock was trading at $156.97 at the start of the year. Since then, BBH stock has increased by 3.6% and is now trading at $162.56.

Top institutional shareholders of VanEck Biotech ETF include Bleakley Financial Group LLC (0.90%), Conservest Capital Advisors Inc. (0.74%), Wealthfront Advisers LLC (0.28%) and Pacific Sun Financial Corp (0.21%).

Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Biotech ETF investors own include Meta Platforms (META), Micron Technology (MU), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), Adobe (ADBE) and Johnson & Johnson (JNJ).

Fund Details

Issuer
Van Eck
Fund Name
VanEck Biotech ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:BBH
Inception Date
12/20/2011
Fund Manager
Hao-Hung Peter Liao, Guo Hua Jason Jin
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
MVIS US Listed Biotech 25 Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
Global
Number of Holdings
25

Fund Statistics

Assets Under Management
$342.55 million
Average Daily Volume
$7.92 thousand
Discount/Premium
-0.05%

Administrator, Advisor and Custodian

Administrator
Van Eck Associates Corporation
Advisor
Van Eck Associates Corporation
Custodian
State Street Bank and Trust Company
Distributor
Van Eck Securities Corporation
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
20
Put Options
3
Call Options
20
Short Interest
5,600 shs

Miscellaneous

Beta
0.73
Creation Unit
50,000
Creation Fee
$500.00
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Top 10 BBH Holdings

BBH Sector Exposure

BBH Industry Exposure


This page (NASDAQ:BBH) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners